These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1498089)

  • 1. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism.
    Okamoto T; Ogiwara H; Hayashi T; Mitsui A; Kawabe T; Yodoi J
    Int Immunol; 1992 Jul; 4(7):811-9. PubMed ID: 1498089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin.
    Hayashi T; Ueno Y; Okamoto T
    J Biol Chem; 1993 May; 268(15):11380-8. PubMed ID: 8496188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs.
    Bednarik DP; Duckett C; Kim SU; Perez VL; Griffis K; Guenthner PC; Folks TM
    New Biol; 1991 Oct; 3(10):969-76. PubMed ID: 1768651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription.
    Hazan U; Thomas D; Alcami J; Bachelerie F; Israel N; Yssel H; Virelizier JL; Arenzana-Seisdedos F
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7861-5. PubMed ID: 2146676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexamethylene bisacetamide activates the human immunodeficiency virus type 1 provirus by an NF-kappa B-independent mechanism.
    Vlach J; Pitha PM
    J Gen Virol; 1993 Nov; 74 ( Pt 11)():2401-8. PubMed ID: 8245855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
    Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ
    EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62.
    Matthews JR; Wakasugi N; Virelizier JL; Yodoi J; Hay RT
    Nucleic Acids Res; 1992 Aug; 20(15):3821-30. PubMed ID: 1508666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
    Duh EJ; Maury WJ; Folks TM; Fauci AS; Rabson AB
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5974-8. PubMed ID: 2762307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione.
    Harper R; Wu K; Chang MM; Yoneda K; Pan R; Reddy SP; Wu R
    Am J Respir Cell Mol Biol; 2001 Aug; 25(2):178-85. PubMed ID: 11509327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells.
    Atwood WJ; Tornatore CS; Traub R; Conant K; Drew PD; Major EO
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1207-11. PubMed ID: 7848678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor.
    Hansen SK; Guerrini L; Blasi F
    J Biol Chem; 1994 Sep; 269(35):22230-7. PubMed ID: 8071349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
    Twu JS; Chu K; Robinson WS
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene products.
    Muchardt C; Seeler JS; Nirula A; Shurland DL; Gaynor RB
    J Virol; 1992 Jan; 66(1):244-50. PubMed ID: 1727488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1.
    Tesmer VM; Rajadhyaksha A; Babin J; Bina M
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7298-302. PubMed ID: 8346247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.
    Clark NM; Hannibal MC; Markovitz DM
    J Virol; 1995 Aug; 69(8):4854-62. PubMed ID: 7609053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.
    Gaynor RB; Kuwabara MD; Wu FK; Garcia JA; Harrich D; Briskin M; Wall R; Sigman DS
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9406-10. PubMed ID: 3200827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
    Schafer SL; Hiscott J; Pitha PM
    Virology; 1996 Oct; 224(1):214-23. PubMed ID: 8862416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
    Burysek L; Yeow WS; Pitha PM
    J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.